IMNN
USDImunon Inc. Common Stock
$3.880-0.310 (-7.399%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$4.190
High
$4.190
Low
$3.840
Volume
0.04M
Company Fundamentals
Market Cap
9.8M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.10M
Exchange
NCM
Currency
USD
52-Week Range
Low $3.84Current $3.880High $41.217392
Related News
GlobeNewswire
IMUNON Announces Webcast of In-Person R&D Day Highlighting Progress on OVATION 3 Study in Pursuit of First Frontline Immunotherapy for Advanced Ovarian Cancer
Investor event in New York City to provide update on pivotal Phase 3 study of IMNN-001; offering in-person or virtual attendance on November 10, 2025 Program will feature presentations from ovarian cancer thought
View more
GlobeNewswire
IMUNON to Present Phase 3 OVATION 3 Study of IMNN-001 in Advanced Ovarian Cancer at IGCS 2025 Annual Global Meeting
Trials-in-progress poster of ongoing pivotal Phase 3 trial of DNA-mediated immunotherapy accepted at both IGCS and ESMO Congress 2025 LAWRENCEVILLE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:IMNN),
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.